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Abstract 
Gamma-aminobutyric acid (GABA) is the major inhibitory neurotransmitter in the brain and is 
implicated in the pathophysiology of a number of neuropsychiatric disorders. The GABAB receptors 
are G-protein coupled receptors consisting of principle subunits and auxiliary potassium channel 
tetramerization domain (KCTD) subunits. The KCTD subunits 8, 12, 12b and 16 are cytosolic proteins 
that determine the kinetics of the GABAB receptor response. Previously, we demonstrated that 
Kctd12 null mutant mice (Kctd12-/-) exhibit increased auditory fear learning and that Kctd12+/- mice 
show altered circadian activity, as well as increased intrinsic excitability in hippocampal pyramidal 
neurons. KCTD16 has been demonstrated to influence neuronal excitability by regulating GABAB 
receptor-mediated gating of postsynaptic ion channels. In the present study we investigated for 
behavioural endophenotypes in Kctd16-/- and Kctd16+/- mice. Compared with wild-type (WT) 
littermates, auditory and contextual fear conditioning were normal in both Kctd16-/- and Kctd16+/- 
mice. When fear memory was tested on the following day, Kctd16-/- mice exhibited less extinction of 
auditory fear memory relative to WT and Kctd16+/- mice, as well as more contextual fear memory 
relative to WT and, in particular, Kctd16+/- mice. Relative to WT, both Kctd16+/- and Kctd16-/- mice 
exhibited normal circadian activity. This study adds to the evidence that auxillary KCTD subunits of 
GABAB receptors contribute to the regulation of behaviours that could constitute endophenotypes 
for hyper-reactivity to aversive stimuli in neuropsychiatric disorders. 
 
Keywords: Gamma-aminobutyric acid; GABAB; KCTD16; fear learning, memory, extinction; 
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BLA basolateral amygdala; Hepes 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid; KCTD  
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1. Introduction 
The GABAB receptors are G-protein coupled receptors for gamma-aminobutyric acid (GABA), the 
major inhibitory neurotransmitter in the mammalian central nervous system (CNS) [1]. They are 
expressed by almost all neurons and glia in the CNS and are major regulators of synaptic transmission 
and neuronal excitability, thereby modulating emotion and cognition [2, 3]. The GABAB receptors are 
hetero-multimers composed of principal and auxiliary subunits. The principal subunits GABAB1a, 
GABAB1b and GABAB2 form fully functional GABAB(1a,2) and GABAB(1b,2) receptors that localize to pre- and 
postsynaptic sites, respectively [4, 5]. These receptors can associate with the cytosolic auxiliary 
potassium channel tetramerization domain (KCTD) subunits KCTD8, KCTD12, KCTD12b or KCTD16. 
The KCTD proteins bind constitutively to GABAB2 to form receptor subtypes that are structurally and 
functionally distinct [6]. The KCTDs simultaneously bind to the GABAB receptor and the G-protein, 
and thereby influence the kinetics of the receptor response via stabilization of the G-protein at the 
receptor and direct effects on G-protein signaling [7].  
 
Postmortem studies have identified decreased GABAB receptor density in patients with schizophrenia 
[8, 9] and decreased GABAB1 and GABAB2 protein expression in patients with schizophrenia, bipolar 
disorder or major depressive disorder (MDD) [10]. Studies in laboratory animals reported increases in 
GABAB receptor density and mRNA expression, or function in response to administration of 
antidepressants [11-14]. In addition, GABAB receptor antagonists showed anxiolytic and 
antidepressant-like activity in a number of animal models [15-19]. Accordingly, GABAB receptors have 
been proposed as a potential treatment target for these major neuropsychiatric disorders as well as 
for anxiety disorders and addiction [20-23]. The KCTD proteins are also associated with 
neuropsychiatric disorders. KCTD12 has been most studied: a genome-wide association study of 
bipolar disorder I patients identified an association with a single nucleotide polymorphism in a region 
that includes KCTD12 [24]; a translational microarray study identified KCTD12/Kctd12 up-regulation 
in the amygdala of MDD patients and stressed mice relative to their respective control groups [25]. 
KCTD16 was identified as a candidate gene for a congenital partial epilepsy syndrome [26]. A KCTD8 
polymorphism was associated with brain size in female adolescents, with its proposed role being 
KCTD8 modulation of the adverse effects of prenatal exposure to maternal cigarette smoking on 
cortical development [27]. 
 
The availability of mice mutant for the GABAB receptor principal subunits has allowed for elucidation 
of their behavioural roles. Thus, genetic ablation of either GABAB1 or GABAB2 , which results in mice 
lacking functional GABAB receptors, induced antidepressant-like behavioural effects [15, 28], 
cognitive impairments [29-31] and alterations in the circadian organization of sleep [32]. The 
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contribution of receptor subtypes to physiological and behavioral GABAB functions was assessed in 
mice lacking specific GABAB1 subunit isoforms [3-5, 33, 34]. In this respect, the emotional processing 
and learning and memory of aversive stimuli have been studied using Pavlovian fear conditioning: an 
initially neutral stimulus, either a discrete event such as a tone (conditioned stimulus, CS) or the 
general context, is paired with an aversive unconditioned stimulus (US), typically a foot shock [35]. 
Fear learning, memory and memory extinction learning are then assessed by measuring freezing to 
the CS or context [35]. In GABAB1a-/- mice i.e. mice lacking the GABAB1 subunit that localizes to 
presynaptic sites, tone CS fear learning and memory were normal relative to wild-type (WT), whilst 
there was an endophenotype of increased generalized fear to a neutral tone CS and a neutral 
context. In GABAB1b-/- mice i.e. mice lacking the GABAB1 subunit that localizes to postsynaptic sites, in 
contrast, fear learning was completely impaired. These critical and distinct roles of specific GABAB1 
subunit isoforms reflect their major involvement in pre- and postsynaptic modulation of the long-
term potentiation induced by thalamo-cortical inputs to the amygdala [36]. In conditioned taste 
aversion (CTA), another form of aversive learning and memory involving pairing of normally 
rewarding sweet taste with malaise induced by lithium chloride injection, GABAB1a-/- mice failed to 
acquire CTA. GABAB1b-/- mice acquired CTA to a similar extent to WT; however, they differed from WT 
in terms of a robust deficit in extinction learning across repeated exposure to the sweet taste in the 
absence of malaise [37]. GABAB1 subunit-specific mutant mice have also been studied in terms of 
circadian activity endophenotypes: GABAB1a-/- mice displayed higher inactive phase activity than WT, 
whereas GABAB1b-/- mice showed active phase hyperactivity relative to WT [38]. Recently, behavioural 
studies have been conducted with mice lacking the gene for specific auxillary KCTD subunits. We 
demonstrated that Kctd12-/- mice have an endophenotype of increased fear learning and that 
Kctd12+/- mice have an endophenotype of hyperactivity during the inactive phase of the circadian 
cycle, relative to WT. Furthermore, in vitro electrophysiological recordings from the hippocampus, a 
region of high Kctd12 expression, revealed an increased intrinsic excitability of pyramidal neurons in 
Kctd12-/- and Kctd12+/- mice relative to WT mice [39]. 
 
The auxillary subunit KCTD16 is highly expressed in a number of brain regions including amygdala and 
hippocampus [40]. It has been demonstrated to regulate the GABAB receptor-mediated gating of 
postsynaptic ion channels [6, 41], which influences neuronal excitability, oscillatory network activity 
and cognitive functions [42-45]. Here we report on experiments conducted with Kctd16-/-, Kctd16+/- 
and WT mice aimed at assessing whether KCTD16 regulates behavioural states that could constitute  
risk factors (endophenotypes) for neuropsychiatric disorders in terms of fear learning and memory 
and circadian activity. 
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2. Material and methods  
2.1. Animals and housing 
Male and female Kctd16+/- mice on a BALB/c background were paired to generate offspring for each 
genotype i.e. WT, Kctd16+/- and Kctd16-/-. Mice were weaned at age 3-4 weeks and ear tissue punches 
were obtained at age 5-7 weeks for genotyping. All animals were caged as littermate pairs-trios in an 
individually-ventilated cage system (IVC), and were maintained on a reversed 12:12 h light-dark cycle 
(white light off at 07:00 h). Temperature was set at 20-22 °C and humidity at 50-60 %. Food 
(Complete pellet, Provimi, Kliba Ltd, Kaiseraugst, Switzerland) and water were both available 
continuously and ad libitum. Mice were handled on three days prior to each experiment, and all tests 
were conducted between 11:00 h and 16:00 h. Each behavioural experiment was performed with 
naive males aged 8-16 weeks, derived from at least five different litters. There was no effect of 
genotype on body weight: WT 24.1 ± 1.4 g, Kctd16+/- 23.8 ± 1.0 g, Kctd16-/- 27.1 ± 1.6 g (p=0.46). All 
procedures were conducted under permits (170/2012, 1897/2015) for animal experimentation 
issued by the Veterinary Office of Zurich or Basel-Stadt, Switzerland. 
 
2.2. Genotyping 
Mice were genotyped by PCR using genomic DNA extracted from ear tissue. To distinguish between 
the WT and knock-out Kctd16 alleles, 34 cycles of PCR with primers P1 (5’-TTT GCC CTT GCC TGC AGG 
T-3’), P2 (5’-ACC GAG AGG ATG CTG AGT C-3’) and P3 (5’- AGC CAA GCT AGC GAA GTT CC-3’) were 
employed (annealing at 53 °C for 30 s and extension at 72 °C for 1 min), generating fragments of 245 
bp for the WT allele and 386 bp for the knock-out allele. 
 
2.3. Western Blotting 
Brain membranes were prepared as previously described [29]. Briefly, mouse brains were hemi-
dissected and homogenized on ice using a Dounce homogenizer in 10 volumes of buffer containing 4 
mM Hepes (pH 7.4), 1 mM EDTA, 1 mM EGTA, and 0.32 M sucrose. Homogenates were cleared by 
centrifugation at 1000 g for 10 min, and the supernatants again centrifuged at 40000 g for 30 min. 
The pellets containing the brain membranes were solubilized by rocking the tubes for 3 h at 4 °C in 
NP-40 buffer (20 mM Tris-HCl pH 7.5, 100 mM NaCl, 1mM EDTA, 0.5 % (v/v) Nonidet P-40) containing 
Complete EDTA-free Protease Inhibitor Cocktail (Roche, 11 836 170 001). Solubilized brain 
membranes were then cleared by centrifugation at 16000 g for 10 min at 4 °C and resolved on 
standard 12 % SDS-PAGE. Proteins were transferred to polyvinylidene difluoride membranes 
(Immobilon-P, Millipore, IPVH00010). Membranes were then blocked in 5 % BSA in PBS containing 
0.1 % Tween-20 (PBST) and probed with the following primary antibodies: Rabbit anti-KCTD8, rabbit 
anti-KCTD12, rabbit anti-KCTD16 (all at 1:2500) [40], rabbit-anti KCTD12b (N-terminal peptide 
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MAMPEKSSDVKPTEEC, at 1:1000) overnight at 4 °C and mouse anti-tubulin (BD Pharmingen, Clone 
5H1, 1:2500) for 1 h at room temperature. Incubation with peroxidase-coupled secondary antibodies 
(Amersham Biosciences, NA931V and NA9340V, 1:10000) was for 1 h at room temperature. Primary 
antibody incubation was in 5 % BSA in PBST and secondary antibody incubation was in 5 % non-fat 
dry milk in PBST. Following antibody incubations, membranes were washed 4 times for 10 min in 
PBST. Western blots were visualized using SuperSignal West Pico Chemiluminescent Substrate 
(Thermo Scientific) and captured under non-saturating conditions with a Fusion FX image acquisition 
system (Vilber Lourmat). 
 
2.4. Open field test 
Naive mice, eight per genotype, were habituated to the remote experimental room for 24 h prior to 
testing. The open field consisted of a black Plexiglas arena measuring 50 (L) x 50 (W) x 40 (H) cm [39]. 
Lighting was set to 15 lux at the arena centre. The arena was cleaned with 70 % ethanol prior to each 
test. The mouse was placed in the centre of the arena to begin the 30 min open field test. Mouse 
location and movement were monitored using a video-tracking system (VideoMot 2, Version 5.76, 
TSE Systems GmbH, Bad Homburg, Germany). The arena floor was divided virtually into centre (30 x 
30 cm) and periphery. The test measures, namely percent time spent in and distance moved per 
region, were analyzed in 5-min bins.  
 
2.5. Fear learning and memory 
Fear conditioning experiments were conducted using an automated apparatus (MultiConditioning 
System, TSE Systems GmbH) as described in detail elsewhere [46, 47]. A dark-walled Plexiglas arena 
(30 x 30 x 24 cm) was placed on an electrified grid floor measuring 30 x 30 cm and comprising 29 
stainless steel rods. A black metal waste tray was placed under the grid floor. Infrared light-beam 
sensors allowed for measurement of movement in three dimensions. Each such conditioning 
chamber, four in total, was placed in an attenuation chamber equipped with a ventilation fan and 
house lights set to give illumination of 8 lux. An electroshock of 2 s duration and 0.2 mA current 
constituted the aversive unconditioned stimulus (US). The discrete conditioned stimulus (CS) 
consisted of a tone (5 kHz, 85 dB) that was presented for 20 s with the final 2 s contiguous with the 
US. Mice were tested in either a CS-US or Context-US fear learning and memory paradigm.  
 
2.5.1. CS-US fear conditioning 
This experiment was conducted on three consecutive days, with eight naive mice per genotype. Day 
1, baseline: Mice were placed in the arena (context) for 15 min without CS or US. Day 2, conditioning: 
Following 120 s adaptation, mice were exposed to six CS-US pairings with an inter-trial interval (ITI) 
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of 120 s. Day 3, fear expression test: For the CS fear expression test mice were placed in a modified 
context: A dark Plexiglas divider containing a door (3.5 (W) x 10 (H) cm) was placed across the centre 
of the arena to form two compartments and the waste tray below the grid floor was changed from 
black to white. After an adaptation time of 180 s mice were exposed to 18 x 30-s CS separated by 90-
s ITI.  
 
2.5.2. Context-US fear conditioning 
This experiment was conducted on two consecutive days, with eight naive mice per genotype. Day 1, 
conditioning: Mice were given 180 s adaptation followed by 6 x 2-s US with an ITI of 138-s. Day 2, 
fear expression test: Mice were tested in the same context for 18 x 60-s trials. 
 
Freezing was defined as the complete absence of movement detection for at least 2 s, and periods of 
freezing were expressed as percent time spent freezing per CS or ITI. Mean % time freezing per 
mouse was calculated for each 2-3 consecutive CSs or ITIs, depending on experiment and phase. 
Distance moved during USs was also measured and used to assess effects of genotype on pain 
reactivity.  
 
2.6. Circadian activity 
Circadian activity of individual mice was studied using IntelliCage (TSE), an automated system for 
monitoring home-cage activity [48]. Each mouse is fitted with a subcutaneous transponder that 
records: visits to the operant devices located in the cage corners; operant nosepokes into a sensor 
(light-barrier) at the two doors per corner that open to allow access to drinking bottles; and the 
number of drinking licks measured via electrical contact of the tongue with the tip of the water bottle 
cap. Each IntelliCage of 55 (W) x 38 (L) x 20 (H) was divided at the centre by a solid PVC barrier to give 
two independent cages each containing two such operant corner units. Each of the four IntelliCages 
used was placed in its attenuation chamber with a reversed 12:12 h dark-light cycle and individual 
ventilation. Naive mice, 6 per genotype, were studied in littermate pairs, each pair in one cage-half. 
For the first five days mice were habituated to the cage with operant doors open, followed by closing 
the doors and operant training with one nosepoke required to open a door for 10 s, for the next five 
days. Data were then collected for 15 days, with output parameters of total visits, nosepokes and 
licks. Behaviour was analyzed continuously across 15 days with each day divided into its 12-h dark 
phase and 12-h light phase. 
 
2.7. Statistical analysis 
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Behavioural data were analyzed using SPSS (version 19, SPSS Inc., Chicago IL, USA). ANOVA was 
conducted with a between-subject factor of genotype and, depending on behavioural test, a within-
subject factor of trial. Linear regression analysis was conducted using GraphPad Prism (Version 6.07). 
Statistical significance was set at p<0.05. Data are presented as mean ± standard error (SEM).  
 
3. Results 
3.1. Generation of Kctd16 deficient mice and effects on protein expression 
Kctd16-/- mice were generated by targeted mutagenesis of the Kctd16 gene in BALB/c embryonic 
stem (ES) cells (Fig. 1A). Correctly targeted ES cells were injected into C57BL/6 blastocysts and 
chimeric males were crossed with BALB/c females. This resulted in a F1 generation of BALB/c 
Kctd16+/- mice heterozygous for the Kctd16 knock-out allele. In all the studies described below we 
used Kdtd16+/+, Kctd16+/- and Kctd16-/- mice derived from Kctd16+/- x Kctd16+/- breeding pairs.  
Kctd16+/- mice expressed 47 % of the KCTD16 protein of WT mice (p<0.0001) in whole brain lysates 
(N=4/group) whilst KCTD16 protein was undetectable in Kctd16-/- mice. There were no compensatory 
alterations in protein levels of GABAB1a,b, GABAB2, KCTD8, KCTD12 or KCTD12b (Fig. 1B).  
 
[Figure 1 about here] 
 
3.2. Open field test 
In the open field test, total distance moved was used as an index of activity, and distance moved in 
the relatively exposed centre as a measure of anxiety i.e. less distance moved in centre equates to 
greater anxiety [39]. For the total distance moved, there was a main effect of 5-min time-interval 
(F(5, 75)=4.610, p<0.001), with mice exhibiting a consistent reduction in activity across the 30-min 
session, as expected for this test. There was no effect of genotype (main or interaction, p≥0.97). For 
the distance moved in centre, there was also no effect of genotype (p≥0.64). 
 
3.3. Fear learning and memory 
3.3.1. CS-US fear conditioning  
On day 1, mice were habituated to the novel context (fear conditioning arena) without electroshock. 
There was no effect of genotype on baseline % time spent freezing, which was consistently low: WT 
5.7 ± 1.4 %, Kctd16+/- 3.0 ± 0.7 %, Kctd16-/- 3.4 ± 0.5 % (p=0.11). On day 2, CS-US conditioning (Fig. 
2A), % time spent freezing during the CS of CS-US trials was measured. There was a main effect of CS-
US trial (F(2, 42)=69.276, p<0.001) indicating the learning of CS fear across successive CS-US pairings. 
CS-US learning was similar across the different genotypes (p≥0.48) (Fig. 2A). There was also no effect 
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of genotype on US reactivity, measured as distance moved (in arbitrary units) during 2-s footshocks: 
WT 901 ± 119, Kctd16+/- 849 ± 103, Kctd16-/- 689 ± 100 (session mean ± SEM, p=0.26). On day 3, fear 
expression test, the memory of CS fear was measured (Fig. 2B). There was a main effect of CS trial on 
% time freezing (F(5, 105)=5.302, p<0.001) indicating a decrease in fear memory across successive 
exposures to the CS in the absence of the US. This occurred in the absence of either a main effect of 
genotype or a genotype x CS trial interaction (p≥0.44) (Fig. 2B). Nonetheless, the mean freezing 
profiles for the different genotypes suggested a reduced attenuation of freezing in Kctd16-/- mice 
relative to the other genotypes. This difference was supported statistically by the significant linear 
regression of % time freezing against CS trial in WT mice (p<0.03) and Kctd16+/- mice (p<0.03), and 
the absence of such regression in Kctd16-/- mice (p=0.48) (Fig. 2C).  
 
3.3.2. Context-US fear conditioning 
On day 1, conditioning, naive mice were exposed repeatedly to the aversive US in the novel context. 
There was a main effect of US trial (F(2, 42)=79.606, p<0.001) indicating the learning of contextual 
fear across successive US presentations. Context-US learning was similar across the different 
genotypes (p≥0.26) (Fig. 2D). On day 2, fear expression test, the memory of contextual fear was 
measured (Fig. 2E). There was a main effect of context trial (F(5, 105)=5.478 p<0.001) indicating a 
decrease in fear memory across successive 60-s trials of exposure to the context in the absence of 
the US. There was also a main effect of genotype (F(2, 21)=5.047, p=0.016): Kctd16-/-mice spent more 
time freezing than did Kctd16+/-mice (p=0.005) with WT mice exhibiting intermediate freezing 
(Kctd16-/- vs WT p=0.20). Kctd16+/- mice showed a borderline non-significant decrease in freezing 
compared to WT mice (p=0.08) (Fig. 2E).  
 
[Figure 2 about here] 
 
 
3.4. Circadian activity 
As expected, activity in IntelliCage was greater during the 12-h dark periods than during the 12-h 
light periods across the 15-day period. This was the case for each genotype, and there was no 
genotype effect on any measure. For example, there were more corner visits during the dark period 
(Fig. 3A) versus light period (Fig. 3D) (main effect of period: F(1, 435)=1232.914, p<0.001) in the 
absence of an effect of genotype (p≥0.84). Also when the dark and light periods were analyzed 
separately, there were no effects of genotype: dark period, visits (p≥0.84, Fig. 3A), nosepokes 
(p≥0.82, Fig. 3B), water licks (p≥0.89; Fig. 3C); light period, visits (p≥0.14, Fig. 3D), nosepokes (p≥0.33, 
Fig. 3E), water licks (p≥0.23, Fig. 3F).  
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[Figure 3 about here] 
 
4. Discussion 
In the present study we investigated for behavioural phenotypes in adult male BALB/c mice with 
either homo- or heterozygous ablation of Kctd16, the gene encoding one of the auxiliary subunits of 
GABAB receptors. Relative to WT littermates, Kctd16+/- mice exhibited the expected 50 % reduction in 
KCTD16 protein expression in the CNS. There was no evidence for compensatory CNS changes in 
expression of the principal subunits GABAB1a, GABAB1b and GABAB2 or the other auxiliary subunits 
KCTD8, 12 and 12b, neither in Kctd16-/- nor in Kctd16+/- mice. We cannot rule out that alterations in 
other receptor systems contribute to the observed behavioral phenotypes. For example, reduced 
GABAB receptor numbers and other changes in the GABAergic system were observed in the 
hippocampus of mGlu7-deficient mice [49]. However, given that KCTD16 polymorphism is associated 
with brain disorder (e.g. [26]), our animal models with a constitutive Kctd16 ablation (homo- or 
heterozygous) are relevant to human disease. Fear conditioned freezing was used to study KCTD16 
effects on aversive learning and memory. In tone CS-US fear conditioning, there was no effect of 
genotype on emotional learning of the CS-US association; there was some evidence for reduced 
extinction of the CS fear memory in Kctd16-/- mice relative to WT and Kctd16+/-. In context-US fear 
conditioning, there was again no effect of genotype on emotional learning; however, context fear 
memory was increased in Kctd16-/- mice relative to Kctd16+/- mice with WT intermediate. There were 
no effects of KCTD16 reduction/depletion on circadian activity. These findings add to the evidence 
that both auxillary KCTD subunits and principal GABAB subunits make distinct contributions to the 
overall regulation of aversive learning and memory processes by GABAB receptors. 
 
The evidence for an absence of KCTD16 involvement in regulation of CS fear acquisition is in contrast 
to that obtained for KCTD12; Kctd12-/- mice exhibited increased CS fear acquisition, suggesting that 
this subunit modulates the extent to which GABAB contributes to CS-US association learning [39]. The 
evidence for mild impairment of extinction of aversive CS memory in Kctd16-/- mice is the first 
evidence for a contribution of the GABAB receptor to extinction in the rodent CS fear conditioning 
paradigm. Extinction constitutes a net reduction in the acquired association between two events 
following exposure to the discontinuation of that association. It is proposed to be an active process 
involving formation of a new, inhibitory memory [50]. Extinction of CS fear memory is associated 
with increased glutamate signaling from the infralimbic cortex onto amygdala and increased long-
term potentiation input onto local GABAergic inhibitory circuits within the amygdala [51-53]. Studies 
in mice with partial or complete ablation of GABAB receptor subunits did not identify any effects on 
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extinction of fear memory [36]. However, in conditioned taste aversion (CTA), GABAB1b-/- mice 
showed a marked and chronic deficit in CS (sweet taste associated with malaise) extinction learning 
[37]. In addition to the reduced aversive-CS extinction endophenotype, Kctd16-/- mice exhibited 
increased aversive-context memory relative to Kctd16+/- mice, with WT mice exhibiting an 
intermediate level of fear memory. Rather than being a deficit in extinction, the high level of context 
fear memory was evident throughout the expression test in Kctd16-/- mice, suggesting that the lack of 
KCTD16 increased memory consolidation. Context-US learning and memory occur primarily in the 
hippocampus, dependent on bidirectional signaling with the basolateral amygdala (BLA) [54, 55]. In 
the adult mouse brain, KCTD16 is expressed in the BLA and the hippocampal formation [40]. Marked 
aversive memories that are resistant to extinction are particularly relevant to trauma- and stress-
related disorders, perhaps most notably posttraumatic stress disorder [56]. A gene-environment 
model approach, for example applying environmental stressors to Kctd16-/- mice, would be relevant 
to explore this further. 
 
The auxillary subunit KCTD16, which as noted above is highly expressed in a number of brain regions 
including amygdala and hippocampus [40], regulates the GABAB receptors with respect to their 
gating of postsynaptic ion channels, such as hyperpolarization-activated cyclic nucleotide gated 
(HCN) channels [6, 41]. As such, it is well placed to influence GABAB modulation of neuronal 
excitability, oscillatory network activity, and cognitive functions such as learning and memory [42-
45]. The different behavioural phenotypes that can be attributed to KCTD16 (present study) and 
KCTD12 [39] coincide with their distinct domain structures and to their being constituents of distinct 
receptor complexes [41, 57]. As a group and individually, therefore, evidence is emerging that 
auxillary KCTD subunits of GABAB receptors are of regulatory relevance to specific learning and 
memory processes that are important in adaptive behaviour and that also underlie important 
psychopathologies in neuropsychiatric disorders.  
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Figure captions 
Figure 1. (A) Generation of Kctd16-deficient mice. The first exon (E1) of the Kctd16 gene was 
replaced with an FRT-flanked neomycin resistance cassette (TK-neo) by homologous recombination 
in embryonic stem (ES) cells. In the targeting vector the neomycin cassette was flanked by genomic 
sequences homologous to the targeting area in the Kctd16 gene (long and short homology arms). The 
PCR primers used for genotyping are indicated by arrowheads (P1, P2 and P3). The sizes of the 
amplified PCR products are indicated in base pairs (bp). (B) Western blot analysis of KCTD16 protein 
expression in whole brain lysates. Kctd16+/- mice express 47% of KCTD16 compared to WT, and 
normal protein levels of GABAB1a,b (GB1a,b), GABAB2 (GB2), KCTD8, KCTD12 or KCTD12b. Asterisk 
indicates cross-reacting bands. 
 
Figure 2. Effects of Kctd16 genotype on tone CS-US (A - C) and Context-US (D and E) fear learning and 
memory, measured as percent time spent freezing. CS-US conditioning: (A) CS learning. (B) CS 
memory expression. (C) Relationship between % time freezing and CS trial as estimated by linear 
least-means squares regression. Solid lines are for the regression equation for each genotype: WT 
F(1,4)=12.45, p<0.03; HET F(1,4)=11.76, p<0.03, KO F(1,4)<1, p=0.48. Context-US conditioning: (D) 
Context learning. (E) Context memory expression. Data are presented as mean ± SEM (N=8 mice per 
genotype per experiment). CS: conditioned stimulus; US: unconditioned stimulus; WT: wild type.  
 
Figure 3. Effects of Kctd16 genotype and time period on activity and operant drinking behaviour in 
IntelliCage during a 15-day period. Dark period (07:00-19:00 h): (A) Total visits to operant corners. (B) 
Total nosepokes in operant corners. (C) Total water licks in operant corners. Light period (19:00-
07:00 h): (D) Total visits to operant corners. (E) Total nosepokes in operant corners. (F) Total water 
licks in operant corners. Each data point is the overall number of occurrences per 12 hours calculated 
from the mean of 15 days per mouse. KCTD: K+-channel tetramerization domain; WT: wild type. Data 
are presented as mean ± SEM (N=6 mice per genotype). 
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